CU Cancer Center welcomes 7 new members
June 16, 2014 · Comments Off
The University of Colorado Cancer Center is pleased to welcome the following new members! James...
CU Cancer Center, MD Anderson awarded joint $4.25M grant to develop early-phase clinical trials
April 17, 2014 · Comments Off
The University of Colorado Cancer Center and The University of Texas MD Anderson Cancer Center...
13 CU Cancer Center researchers receive cumulative $1M for translational cancer research.
March 12, 2014 · Comments Off
The University of Colorado Cancer Center has awarded more than $1M in grant funding to 13...
Cancer fight enters the next generation
February 24, 2014 · Comments Off
Sophisticated equipment at the Colorado Molecular Correlates Laboratory (CMOCO) processes millions of sequences of DNA in a search for cancer-causing mutations that can be treated with targeted therapies.
CU Cancer Center members awarded grants from Alex’s Lemonade Stand
February 10, 2014 · Comments Off
A University of Colorado Cancer Center member is one of the first scientists to receive...
CU Cancer Center welcomes 10 new members
November 13, 2013 · Comments Off
The University of Colorado Cancer Center is pleased to welcome the following new members! Tullika...
IASLC Names Fred R. Hirsch, MD, PhD as New CEO
November 6, 2013 · Comments Off
The International Association for the Study of Lung Cancer (IASLC) Board of Directors has selected Fred R. Hirsch, MD, PhD as the organization’s new Chief Executive Officer (CEO). Hirsch takes over for the current CEO, Paul A. Bunn, Jr., MD.
New Cell Sorter Speeds Research at University of Colorado Cancer Center
October 16, 2013 · Comments Off
Purchased with $400k from the Dean's Academic Enrichment Fund, and additional monies from the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and the CU Cancer Center, the new MoFlo Astrios EQ cell sorter allows more sensitive, faster sorting.
Ed Bedrick named director of CU Cancer Center’s Biostatistics and Bioinformatics Shared Resource
July 26, 2013 · Comments Off
Prominent statistician Ed Bedrick, PhD, has joined the University of Colorado Cancer Center as the director of the Biostatistics and Bioinformatics Shared Resource.
NTRK1: a new oncogene and target in lung cancer
July 26, 2013
NEJM: Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer
September 30, 2014 · No comments
ALK amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado cancer stem cells Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant james degregori jennifer richer leukemia lung cancer lung cancer research melanoma microRNA ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
CU Cancer Center researcher looks into female sexual health after cancer treatment. “This is a subject that no... fb.me/6OkYVDAdD
Race for the Cure is tomorrow! We hope to see you there! fb.me/6BZ6FkEi0
Did you know that breast cancer is the second leading cause of death in women? Take part in this year's Race for... fb.me/2zSQzD20E